Background: Extravasation of intravenous chemotherapeutic agents is one of the most devastating complications, which unacceptable condition neither to patient nor to medical services. Many healthcare providers realize that even one extravasation injury is too many since this injury is preventable. Published incidence rates of chemotherapy extravasation range from 0,01% to 6%, but in our institution, chemotherapy extravasation was not well recorded, so the incidence rate is unclear and the number of injuries is underestimated.
INTRODUCTION
Cytotoxic drugs in the treatment of malignancy are well established, and the role of systemic intravenous chemotherapeutic agents is increasing day by day.
1, 2 In addition to their therapeutics on malignant cells, cytotoxic agents have the potential of causing the destruction of healthy cells.
3,4,5 For all types of chemotherapeutic agents, extravasation is feared and serious complication, the tissue damage may progress over days and weeks and cause pain, necrosis of skin, subcutaneous tissue, nerves, tendon, and vessels damage. Patients also suffer from functional defects, physiological distress, cosmetic changes, infection, and interruption of their treatment.
2,3,5,6,7,14
Another consequence is litigation -nurses are now being named in malpractice allegations and extravasation injury are an area for concern. The frequency of cytotoxic drugs extravasation in adults is considered to be between 0,01% and 6%.
3,4,5,8,10
Based on their potential to cause local tissue injury, drugs are classified as vesicant and irritant (table 1) . Vesicant drugs have the capability to induce the formation of blister and or cause tissue damage.
1,9 Irritant drugs can cause pain at the injection pain, with or without an inflammatory reaction, these drugs have the potential to cause soft tissue ulcers only if a large amount of concentrated drug solution is inadvertently extravasted.
1,9
Cytotoxic extravasation should lead us to be more aware of it, better to diagnose and treat it quickly to avoid sequelae or even better to avoid it by taking care of the venipunctures and infusions.
Adequate identification of the potential factors for extravasation is important to minimize the risk in some patients. In the case of an increased risk of extravasation, preventive measures should be encouraged or in some cases, insertion of a CVAD (Central Venous Access Device) should be considered. These factors can be classified under patient associated and procedure risk factors.
10
Management of chemotherapy extravasation divided into pharmacological management (e.g using antidotes or corticosteroids) and non-pharmacological management (e.g heat application, topical cooling or surgery).
8, 12 But extravasation has been termed "a preventable catastrophe", so the best management is prevention, in every department where anticancer chemotherapy is administered regularly, should establishing an adequate protocol and training the medical staff, 13 having legitimate documentation and revised "extravasation kit". 
RESULT
Totally 1374 chemotherapy administered, there were 10 patients (table 3) out of which eight were females (80%) and two were males (20%) have cytotoxic drug extravasation. They were aged 34-63 years, with the mean age of 45,6 years. Most of the patients belonged from lower socioeconomic strata and not well educated. Doxorubicin was responsible for extravasation side effects in all cases.
In term of the area involved, the dorsum of the hand was involved in 6 cases (60%), the wrist in one case (10%), forearm in three cases (30%), cubital fossa and a lower leg each in one case (10%). There was one case with bulae and erythema, one case with massive subcutaneous abscess, and the remaining eight cases had dry tissue necrosis. None of the patients had any nerve, vessels or bone exposure. Nine cases had immediate management consisted of hot or cold compressed only (90%) and one must undergo debridement (10%). All of them used peripheral vena access with abbocath size 20-22 G. After the incidence, eventually, two cases (20%) have implanted port placed.
DISCUSSION
The etiopathogenesis of tissue damage by extravasation of drugs enumerated in literature includes direct cellular toxicity of the drug, vasoconstriction leading to ischemic necrosis, osmotic damage, extrinsic mechanical compression by large volumes of extravasated solutions which again leads to ischemic necrosis and superimposed infection of skin sloughing occurs.
5
The majority of the patients will complain of excruciating pain and itching in the infusion site. Within a few hours, the extravasation area will show erythema, edema, and induration. Within a few days, these sign and symptom will increase and the skin will show discoloration and desquamation of the epidermis or If a large dose of a cytotoxic drug is extravasated, the area will show ischemic changes and ulcer formation will be inevitable. In Indonesia, there still no legitimate documentation of cytotoxic drug extravasation, so the incidence still unclear. Many health providers with cancer center underestimating this injury, so there were no guidelines or protocol either no trained staff to early detect and to manage the extravasation. The used of CVAD still rare because of the price, but never compared with the cost of prolonged hospitalization, extra surgical management, and legitimate side.
This study was very limited, need more data and more time, but can be a starter to increase the awareness all health providers who have cancer center especially in Indonesia. Maybe in the next step, we will have extravasation guidelines, more trained staff and national health insurance covers the used of CVAD. 
